CNS Pharmaceuticals, Inc. (CNSP) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $18.2K | +334.0% |
| 2024 | $4.2K | +7.4% |
| 2023 | $3.9K | -11.8% |
| 2022 | $4.4K | -23.1% |
| 2021 | $5.7K | -68.0% |
| 2020 | $17.9K | -10.8% |
| 2019 | $20.1K | — |
| 2018 | $0 | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $18.2K | +334.0% |
| 2024 | $4.2K | +7.4% |
| 2023 | $3.9K | -11.8% |
| 2022 | $4.4K | -23.1% |
| 2021 | $5.7K | -68.0% |
| 2020 | $17.9K | -10.8% |
| 2019 | $20.1K | — |
| 2018 | $0 | — |